A scientific and technology business called Merck KGaA produces pharmaceutical and chemical items. It works in the healthcare, bioscience, and performance chemicals industries. The healthcare industry finds, creates, and makes prescription drugs that are used to treat conditions like cancer, multiple sclerosis, as well as fertility. The life sciences industry offers tools, services, and technologies for laboratories to scientists. For difficult applications, the performance materials industry provides specialised chemical products. Pharma and biopharma production, pharmaceutical research, pharmaceutical quality assurance, as well as services for government and university research are all provided by the company. Friedrich Jacob Merck established the business, which has its headquarters in Darmstadt, Germany, in 1668.
A division of E. Merck KG is the science and technology firm Merck KGaA (Merck). It also creates liquid crystal blends, organic light-emitting diode (OLED) resources, cosmetic active substances, coating pigments, and high-tech components. These drugs are prescribed to treat cancer, multiple sclerosis, and infertility. Additionally, Merck provides a diverse range of goods, such as end-to-end systems, cell lines, antibodies, lab water systems, gene editing tools, and tools for editing genes. The business provides services to the life sciences, functional value, and healthcare sectors. It is present in the Middle East, Africa, Latin America, North America, and Asia-Pacific. The headquarters of Merck are in Darmstadt, Hesse, Germany.
Under this ticker, Merck is publicly traded.
11 investments have been made by Merck. Aktis Oncology acquired $84M on August 25, 2022, marking their most latest investment.
RxAll received funding from Merck on August 25, 2022. This investment – Grant – RxAll – was valued at $84M.
Merck has had 3 exits. Merck’s most notable exits include Moderna Therapeutics, Threshold Pharmaceuticals, and Idera Pharmaceuticals.
Merck has acquired 15 organizations. Their most recent acquisition was Chord Therapeutics on Dec 20, 2021.
Determine Merck KGaA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
Proactively evaluate Merck KGaA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Merck KGaA’s relevant decision makers and contact details.
Understand Merck KGaA’s commercialized product portfolio to stay one step ahead of the market.
Identify which of Merck KGaA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
Sales & Consensus Forecasts
Understand the current and future drug revenue for Merck KGaA and assess market opportunity for new entrants with patient population 8-year forecasts.
Track drug and patent expiries along with geographies impacted.
Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.
Medical Marketed Products
A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.
Medical Clinical Trials
A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.
Medical Pipeline Products
A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.
IT Services Contracts
Improve competitive bidding with insights into all publicly disclosed IT services contracts for Merck KGaA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).
IT Software Contracts
Improve competitive bidding with insight into all publicly disclosed IT software contracts by IT solutions areas for Merck KGaA (including Enterprise applications, IT Security, Information Management, Cloud Computing, IoT and more).
ICT Spend & Tech Priorities
IT Client Prospector provides intelligence on Merck KGaA’s likely spend across technology areas enabling you to understand the digital strategy.